23 April 2021 - Deborah Wilkes
Premium
Johnson & Johnson (J&J) reported a double-digit drop in its OTC sales during the first quarter of 2021, as the COVID-19 pandemic took its toll in multiple ways.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.